ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Cuprina (CUPR)
Cuprina stock price today, ATLAS forecast and fair value
Healthcare · Medical Instruments & Supplies · NASDAQ
$1.80▲ 0.00%
Prices as of Oct 26, 2026 · USD
Chance of rising in 1 month
41%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Cuprina in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Cuprina
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Cuprina a 41% chance of finishing higher a month from now (21 trading sessions) than today: somewhat worse than a coin flip.
In half of the simulated outcomes the price ends between $1.31 and $2.12; in 9 out of 10, between $0.86 and $3.25. Estimated annual volatility is 149%.
Price, last 12 months (weekly close)
Key numbers
- 52-week high
- $8.41
- 52-week low
- $1.45
- Revenue (12 months)
- $0.0M
- Revenue growth (YoY)
- +3.3%
- Gross margin
- -1.3%
- Free cash flow (12 months)
- $-4.7M
- Beta
- 0.00
What this means
ATLAS does not publish a fair value for CUPR right now, but it does show its odds of rising: somewhat worse than a coin flip.
Over the last 52 weeks CUPR has traded between $1.45 and $8.41. Today it is 78.6% below that high and 24% above its low.
Its beta is 0.00: it tends to move less than the market.
About the company
Cuprina Holdings (Cayman) Limited is a biomedical and biotechnology company focused on developing and commercializing products for chronic wound management, infertility, medical waste recycling, and cosmeceuticals.
Want to see everything about Cuprina?
Get started →Plans from €3.99 a month.
Frequently asked questions
What does Cuprina do?
Cuprina Holdings (Cayman) Limited is a biomedical and biotechnology company focused on developing and commercializing products for chronic wound management, infertility, medical waste recycling, and cosmeceuticals.
What is the chance CUPR goes up next month?
41%: somewhat worse than a coin flip. In half of the simulated outcomes, CUPR ends the month between $1.31 and $2.12.
How volatile is CUPR?
ATLAS estimates annual volatility at 149%. In a typical month, half of the outcomes end between $1.31 and $2.12.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer